Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Journal of Clinical Pharmacy and Therapeutics
|
March 19, 2022
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndrome
Bradley P Dixon, Ashley Sabus
Pediatric Clinics of North America
|
November 21, 2018
Hemolytic Uremic Syndrome
Ellen M Cody, Bradley P Dixon
Pediatric Nephrology (Berlin, Germany)
|
March 4, 2025
Assessing C3 glomerulopathy outcomes in children: how concerned should we be?
Russell S Whelan, Bradley P Dixon
Pediatric Nephrology (Berlin, Germany)
|
February 19, 2005
A mechanistic approach to inherited polycystic kidney disease
John J Bissler, Bradley P Dixon
Pediatric Clinics of North America
|
May 28, 2018
Atypical Hemolytic Uremic Syndrome
Bradley P Dixon, Ralph A Gruppo
Current Treatment Options in Pediatrics
|
August 22, 2018
Management of Hematuria in Children
O N Ray Bignall, Bradley P Dixon
Pediatric Nephrology (Berlin, Germany)
|
February 16, 2005
Neonatal renovascular hypertension due to prenatal traumatic retroperitoneal hematoma
Bradley P Dixon, Prasad Devarajan, Mark Mitsnefes
Clinical Nephrology. Case Studies
|
July 18, 2019
Comorbidity of inflammatory bowel disease with atypical hemolytic uremic syndrome in pediatric patients
H Stella Shin, Carla M Nester, Bradley P Dixon
Nephron. Experimental Nephrology
|
November 13, 2010
Tuberous sclerosis complex renal disease
Bradley P Dixon, John C Hulbert, John J Bissler
Mutation Research
|
June 28, 2008
RecQ and RecG helicases have distinct roles in maintaining the stability of polypurine.polypyrimidine sequences
Bradley P Dixon, Lu Lu, Albert Chu, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Journal of Clinical Pharmacy and Therapeutics
|
March 19, 2022
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndrome
Bradley P Dixon, Ashley Sabus
Pediatric Clinics of North America
|
November 21, 2018
Hemolytic Uremic Syndrome
Ellen M Cody, Bradley P Dixon
Pediatric Nephrology (Berlin, Germany)
|
March 4, 2025
Assessing C3 glomerulopathy outcomes in children: how concerned should we be?
Russell S Whelan, Bradley P Dixon
Pediatric Nephrology (Berlin, Germany)
|
February 19, 2005
A mechanistic approach to inherited polycystic kidney disease
John J Bissler, Bradley P Dixon
Pediatric Clinics of North America
|
May 28, 2018
Atypical Hemolytic Uremic Syndrome
Bradley P Dixon, Ralph A Gruppo
Current Treatment Options in Pediatrics
|
August 22, 2018
Management of Hematuria in Children
O N Ray Bignall, Bradley P Dixon
Pediatric Nephrology (Berlin, Germany)
|
February 16, 2005
Neonatal renovascular hypertension due to prenatal traumatic retroperitoneal hematoma
Bradley P Dixon, Prasad Devarajan, Mark Mitsnefes
Clinical Nephrology. Case Studies
|
July 18, 2019
Comorbidity of inflammatory bowel disease with atypical hemolytic uremic syndrome in pediatric patients
H Stella Shin, Carla M Nester, Bradley P Dixon
Nephron. Experimental Nephrology
|
November 13, 2010
Tuberous sclerosis complex renal disease
Bradley P Dixon, John C Hulbert, John J Bissler
Mutation Research
|
June 28, 2008
RecQ and RecG helicases have distinct roles in maintaining the stability of polypurine.polypyrimidine sequences
Bradley P Dixon, Lu Lu, Albert Chu, et al.
Page
of 7